Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ALZN
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Milton C. Ault III Director | ALZN Alzamend Neuro, Inc. | Sale | 2,000 | $1.56 | $3,120 Sale | Form 4 ↗ |
| Apr 14, 2026 | Milton C. Ault III Director | ALZN Alzamend Neuro, Inc. | Buy | 2,000 | $1.03 | $2,060 Buy | Form 4/A ↗ |
| Apr 14, 2026 | Milton C. Ault III Director | ALZN Alzamend Neuro, Inc. | Buy | 108,388 | $1.00 | $108.4K Buy | Form 4/A ↗ |
| Apr 14, 2026 | Milton C. Ault III Director | ALZN Alzamend Neuro, Inc. | Buy | 2,000 | $1.03 | $2,060 Buy | Form 4/A ↗ |
| Apr 14, 2026 | Milton C. Ault III Director | ALZN Alzamend Neuro, Inc. | Buy | 108,388 | $1.00 | $108.4K Buy | Form 4/A ↗ |
| Dec 23, 2025 | Milton C. Ault III Director | ALZN Alzamend Neuro, Inc. | Sale | 1,851 | $2.07 | $3,832 Sale | Form 4 ↗ |
| Dec 19, 2025 | William B. Horne Director | ALZN Alzamend Neuro, Inc. | Sale | 3,333 | $2.12 | $7,066 Sale | Form 4 ↗ |
| Oct 23, 2025 | Lynne Fahey McGrath Director | ALZN Alzamend Neuro, Inc. | Sale | 30 | $2.29 | $68.7 Sale | Form 4 ↗ |
| Oct 9, 2025 | Milton C. Ault III Director | ALZN Alzamend Neuro, Inc. | Sale | 20,397 | $2.32 | $47.3K Sale | Form 4 ↗ |
| Oct 8, 2025 | Milton C. Ault III Director | ALZN Alzamend Neuro, Inc. | Sale | 101,394 | $2.44 | $247.4K Sale | Form 4 ↗ |
| Oct 7, 2025 | Milton C. Ault III Director | ALZN Alzamend Neuro, Inc. | Sale | 57,379 | $2.49 | $142.9K Sale | Form 4 ↗ |
| Oct 6, 2025 | Milton C. Ault III Director | ALZN Alzamend Neuro, Inc. | Sale | 82,033 | $2.45 | $201.0K Sale | Form 4 ↗ |
| Oct 3, 2025 | Milton C. Ault III Director | ALZN Alzamend Neuro, Inc. | Sale | 65,903 | $2.44 | $160.8K Sale | Form 4 ↗ |
| Oct 2, 2025 | Milton C. Ault III Director | ALZN Alzamend Neuro, Inc. | Sale | 20,686 | $2.39 | $49.4K Sale | Form 4 ↗ |
| Oct 1, 2025 | Milton C. Ault III Director | ALZN Alzamend Neuro, Inc. | Sale | 36,777 | $2.35 | $86.4K Sale | Form 4 ↗ |
| Sep 30, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 3,566 | $2.33 | $8,309 Sale | Form 4 ↗ |
| Sep 29, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 38,324 | $2.31 | $88.5K Sale | Form 4 ↗ |
| Sep 26, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 37,738 | $2.31 | $87.2K Sale | Form 4 ↗ |
| Sep 25, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 14,628 | $2.31 | $33.8K Sale | Form 4 ↗ |
| Sep 24, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 39,140 | $2.31 | $90.4K Sale | Form 4 ↗ |
| Sep 23, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 43,238 | $2.38 | $102.9K Sale | Form 4 ↗ |
| Sep 19, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 77,009 | $2.35 | $181.0K Sale | Form 4 ↗ |
| Sep 18, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 20,870 | $2.47 | $51.5K Sale | Form 4 ↗ |
| Sep 17, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 2,121 | $2.45 | $5,196 Sale | Form 4 ↗ |
| Jul 31, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 100,000 | $2.22 | $222.0K Sale | Form 4 ↗ |
| Jul 30, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 29,449 | $2.51 | $73.9K Sale | Form 4 ↗ |
| Jul 28, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 8,311 | $2.68 | $22.3K Sale | Form 4 ↗ |
| Jul 25, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 36,532 | $2.90 | $105.9K Sale | Form 4 ↗ |
| Jul 24, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 9,621 | $2.93 | $28.2K Sale | Form 4 ↗ |
| Jul 23, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 59,516 | $2.95 | $175.6K Sale | Form 4 ↗ |
| May 12, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 11 | $5.28 | $58.08 Sale | Form 4 ↗ |
| May 12, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Sale | 1,213 | $5.06 | $6,138 Sale | Form 4 ↗ |
| Mar 26, 2025 | William B. Horne Director | ALZN Alzamend Neuro, Inc. | Buy | 3,334 | $0.99 | $3,301 Buy | Form 4 ↗ |
| Mar 21, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Buy | 2,905 | $1.02 | $2,963 Buy | Form 4 ↗ |
| Mar 21, 2025 | David J. Katzoff Chief Financial Officer | ALZN Alzamend Neuro, Inc. | Buy | 5,000 | $1.01 | $5,050 Buy | Form 4 ↗ |
| Mar 20, 2025 | William B. Horne Director | ALZN Alzamend Neuro, Inc. | Buy | 5,000 | $0.98 | $4,900 Buy | Form 4 ↗ |
| Mar 18, 2025 | William B. Horne Director | ALZN Alzamend Neuro, Inc. | Buy | 5,000 | $0.97 | $4,850 Buy | Form 4 ↗ |
| Mar 18, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Buy | 5,000 | $0.96 | $4,800 Buy | Form 4 ↗ |
| Mar 12, 2025 | Milton C. Ault III Director, 10% owner | ALZN Alzamend Neuro, Inc. | Buy | 100 | $0.68 | $68 Buy | Form 4 ↗ |
39 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:03 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances